Science Corp's brain tech hits $3.5B with new funding
science corporation raised $400m at $3.5b valuation for brain tech. affects biotech and medical tech industries.
science corporation, founded by former neuralink president max hodak in 2021, raised $400m in series d funding at a $3.5b valuation. the company's first product, prima, is a wearable and implantable chip that helps people with age-related macular degeneration recover some vision. prima is approved in europe and available in germany, and is being trialled for new conditions, including stargardts disease. with this funding, science aims to bring prima to the us market through the fda's humanitarian device exemption.